Coremax Corporation (4739.TW)
Hsinchu City, TW
Coremax Corporation, established in 1992 and headquartered in Hsinchu City, Taiwan, specializes in the research, development, manufacturing, and distribution of metal-based specialty chemicals and materials for the electronics and battery sectors throughout Taiwan. Its diverse product offerings encompass oxidation catalysts, available in both liquid and crystalline forms, as well as a range of specialty chemicals for use in industries such as tire production, pigments, paints, and other electronic and traditional applications. The company also provides essential battery materials crucial for the fabrication of rechargeable lithium-ion batteries, in addition to supplying chemical and organic compound fertilizers. Originally known as Coremax Taiwan Corporation, the company adopted its current name, Coremax Corporation, in the year 2000.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.97% | +13.66% | +22.93% | +46.27% | +48.57% | +59.51% | +114.21% | +20.96% | +63.55% | +149.64% | +399.76% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+51.2% ★ Q1'26: +125.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+12.2% Q1'26: +756.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-14.7% Q1'26: -18.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.1% Q1'26: +13.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.7% Q1'26: +12.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-20.5% ★ Q1'26: +23.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.85× Q1'26: 3.68× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.99B
est: 4.00B (-0.2%)
|
4.98B
est: 5.00B (-0.4%)
|
6.31B
est: 6.32B (-0.1%)
|
6.37B
est: 6.54B (-2.6%)
|
5.29B
est: 5.72B (-7.6%)
|
7.34B
est: 7.31B (+0.5%)
|
9.08B
est: 9.24B (-1.7%)
|
5.23B
est: 5.23B (0.0%)
|
4.10B
est: 4.09B (+0.2%)
|
6.19B
est: 5.34B (+15.9%)
|
6.26B
6.26B – 6.26B
+17.1% YoY
|
| EBITDA |
461.94M
est: 451.98M (+2.2%)
|
741.11M
est: 565.08M (+31.2%)
|
797.62M
est: 713.67M (+11.8%)
|
503.34M
est: 738.98M (-31.9%)
|
499.56M
est: 646.33M (-22.7%)
|
919.51M
est: 825.48M (+11.4%)
|
1.07B
est: 1.04B (+2.8%)
|
335.32M
est: 591.18M (-43.3%)
|
667.26M
est: 489.03M (+36.4%)
|
789.56M
est: 638.88M (+23.6%)
|
748.44M
748.44M – 748.44M
+17.1% YoY
|
| EBIT |
303.38M
est: 242.51M (+25.1%)
|
567.37M
est: 303.20M (+87.1%)
|
583.29M
est: 382.92M (+52.3%)
|
268.10M
est: 396.50M (-32.4%)
|
225.52M
est: 346.79M (-35.0%)
|
629.97M
est: 442.91M (+42.2%)
|
784.02M
est: 559.95M (+40.0%)
|
24.00M
est: 317.20M (-92.4%)
|
342.83M
est: 270.68M (+26.7%)
|
436.59M
est: 353.62M (+23.5%)
|
414.26M
414.26M – 414.26M
+17.1% YoY
|
| Net Income |
216.66M
est: 465.84M (-53.5%)
|
411.53M
est: 561.61M (-26.7%)
|
393.02M
est: 612.12M (-35.8%)
|
128.02M
est: 263.10M (-51.3%)
|
155.16M
est: 122.21M (+27.0%)
|
462.93M
est: 545.50M (-15.1%)
|
493.16M
est: 636.11M (-22.5%)
|
-100.23M
est: -98.80M (-1.5%)
|
169.04M
est: 146.26M (+15.6%)
|
184.31M
est: 33.38M (+452.2%)
|
304.30M
304.30M – 304.30M
+811.8% YoY
|
| SGA |
209.47M
est: 216.84M (-3.4%)
|
215.44M
est: 271.11M (-20.5%)
|
203.11M
est: 342.39M (-40.7%)
|
224.59M
est: 354.54M (-36.7%)
|
229.73M
est: 310.08M (-25.9%)
|
328.99M
est: 396.04M (-16.9%)
|
421.13M
est: 500.69M (-15.9%)
|
259.10M
est: 283.63M (-8.6%)
|
355.74M
est: 237.59M (+49.7%)
|
389.66M
est: 310.40M (+25.5%)
|
363.62M
363.62M – 363.62M
+17.1% YoY
|
| EPS |
2.89
est: 3.75 (-23.0%)
|
5.23
est: 4.52 (+15.6%)
|
4.45
est: 4.93 (-9.7%)
|
1.35
est: 2.12 (-36.3%)
|
1.72
est: 0.98 (+74.7%)
|
4.64
est: 4.39 (+5.6%)
|
4.69
est: 5.12 (-8.5%)
|
-0.93
est: -0.80 (-16.9%)
|
1.44
est: 1.48 (-2.8%)
|
1.56
est: 0.34 (+361.3%)
|
3.08
3.08 – 3.08
+811.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 32.3K | 0.42% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 127.5K | 0.65% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 287.8K | 0.46% |
| 4 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 32.4K | 0.56% |
| 5 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 42.1K | 0.44% |
| 6 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 436.5K | 0.39% |
| 7 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.00% | 9.0K | 0.35% |
| 8 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 287.4K | 0.29% |
| 9 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 6.3K | 0.33% |
| 10 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 223.7K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Eugene Lawrence | GM & Representative Director | 7M | male |
| Chi-Cheng | Chairman | 7M | male |
| Yuh-Ren Chu | Deputy General Manager | 3M | male |
| Poju Lu | Supervisor of Accounting Division, Manager of Finance Department & Accounting Manager | 2M | male |
| Chao-Hui Huang | Chief Technology Officer & Director | — | — |
| Chih-Hsien Weng | Chief Finance Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4739.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
